Appropriates $5 million from the General Fund to the Department of Health and Human Services, Division of Public Health for 2023-24 to be used to award grants to nonprofit community health centers for the purchase and provision of long-acting reversible contraceptives for underserved, uninsured, or medically indigent patients. Defines long-acting reversible contraceptives to mean a drug or device that meets four specified criteria, including that the design is a temporary method of birth control that can be discontinued and is an FDA approved contraceptive. Effective July 1, 2023.